Recent findings in the pathophysiology and monitoring of hemostasis in patients with end
stage liver disease have major impact on coagulation management during liver …

Background Gaps of knowledge still exist about the potential association between severe
thrombocytopenia and increased risk of procedure‐associated bleeding in patients with liver …

Hemorrhage in the setting of severe trauma is a leading cause of death worldwide. The
pathophysiology of hemorrhage and coagulopathy in severe trauma is complex and remains …

Background: Plasma transfusions are most commonly used therapeutically for bleeding or
prophylactically in non-bleeding patients prior to invasive procedures or surgery. Although …

BACKGROUND Cryoprecipitate was developed for the treatment of inherited and acquired
coagulopathies. The role of cryoprecipitate in hemorrhaging trauma patients is still …

Over the last decade, trends in fluid resuscitation have changed dramatically as have our
practices. Research is driving trauma centers across the globe to initiate modifications in …

The collective of trauma patients is heterogeneous. Despite the lack of evidence, there are
strong arguments for individualized patient treatment with coagulation factors for some …

Massive traumatic haemorrhage is aggravated through the development of trauma-induced
coagulopathy, which is managed by plasma transfusion and/or fibrinogen concentrate …

Improving outcome of trauma patients by implementing patient... : Current Opinion in
Anesthesiology Improving outcome of trauma patients by implementing patient blood …

Haemorrhage), 13, 14 frontline physicians cannot predict with certainty those patients who
will require a massive transfusion and those in whom the surgeon will obtain early control of …